AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $62.57M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| CKA | Ann: Funding Update | 24/04/18 | 194 | 32K | |||
|
|||||||
| CKA | CKA vs Others | 18/04/18 | 318 | 63K | |||
|
|||||||
| CKA | Note 12 - Contingent Liabilities and Contingent assets | 15/04/18 | 13 | 1.9K | |||
|
|||||||
| CKA | Ann: Update on Coal Off-Take LOI and Coal Sales | 06/04/18 | 162 | 52K | |||
|
|||||||
| CKA | Ann: Supplementary Prospectus - Amended Closing Date | 06/04/18 | 82 | 16K | |||
|
|||||||
| CKA | CKA going forward | 25/03/18 | 369 | 92K | |||
|
|||||||
| CKA | Ann: Half Yearly Report | 20/03/18 | 5 | 1.2K | |||
|
|||||||
| CKA | Ann: Response to ASX Query Appendix 5B | 13/03/18 | 14 | 4.0K | |||
|
|||||||
See All Discussions
